$NKTR I wanted to ask biotech folks here. It would actually be logical for BMY to acquire NKTR if the readouts could be as significant as some of you predict. I saw some of you putting BO targets of 60-80 USD. That would be something like 15-20 billion market cap. BMY currently has market cap of 126 billion. Is it possible and does it ever happen BP purchase a company which constitutes 15 percent of their market cap. Just wanted to hear your thoughts if it's likely because it seems a lot.